BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• FDA

  New York-Based Transluminal Tech Grabs E.U. Win For Bioabsorbable Vascular Closure

  August 4, 2014

   · 

  2 min read
• Policy

  Galectin Therapeutics Responds To Class Action Lawsuit

  August 4, 2014

   · 

  3 min read
• Business

  Aldeyra Therapeutics Reports Second Quarter 2014 Financial Results

  August 4, 2014

   · 

  10 min read
• Biotech Beach

  Apricus Biosciences Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc.

  August 4, 2014

   · 

  4 min read
• Drug Development

  Heat Biologics Amends Bladder Cancer Protocol For Early Advancement Into Phase 2 Clinical Studies

  August 4, 2014

   · 

  6 min read
• Business

  Capricor Therapeutics, Inc. To Hold Second Quarter 2014 Business Update Conference Call On August 13, 2014 At 4:30 P.M. Eastern Time

  August 4, 2014

   · 

  3 min read
• Business

  FEI Company Reports New Advances In Neuroscience In Collaboration With National Institutes of Health (NIH)

  August 4, 2014

   · 

  5 min read
• Drug Development

  Hemispherx Biopharma’s Two Drugs, Ampligen® And Alferon® Ranked Highly In Sensitivity Testing Against MERS/SARS Coronaviruses

  August 4, 2014

   · 

  6 min read
• Business

  Hyperion Therapeutics To Report Second Quarter 2014 Financial Results After Market On August, 7, 2014

  August 4, 2014

   · 

  1 min read
• Drug Development

  Mologen AG: First Approvals For Phase III IMPALA Colorectal Cancer Study

  August 4, 2014

   · 

  4 min read